Nephros (NEPH) Current Leases (2019 - 2020)
Nephros (NEPH) recorded quarterly Current Leases of $332000.0 in Q4 2020, up 1.84% quarter-over-quarter from $326000.0 in Q3 2020, and up 26.72% on a YoY basis from $262000.0 in Q1 2020.
Nephros (NEPH) Current Leases (2019 - 2020) Analysis & Trends
Nephros' Current Leases history runs 2 years deep, the most recent figure standing at $332000.0 for Q4 2020.
- In Q4 2020, Current Leases rose 26.72% year-over-year to $332000.0; the TTM figure through Dec 2020 stood at $332000.0 (up 26.72% YoY), while the FY2020 annual figure was $332000.0, up 26.72% from the prior year.
- Current Leases was $332000.0 for Q4 2020 at Nephros, up from $326000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $332000.0 in Q4 2020 to a low of $191000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 29.23 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 21.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 326,000.00 |
| Jun 30, 2020 | 315,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Dec 31, 2019 | 262,000.00 |
| Sep 30, 2019 | 251,000.00 |
| Jun 30, 2019 | 223,000.00 |
| Mar 31, 2019 | 191,000.00 |